Sanda, M.G.

prostate speci antigen cancer speci ficity biopsy detection free-to-total psa study free-to-total prostate cancer ficity p 2psa gleason prostate health index 10 ng /ml result sensitivity pca detection range score probability participant signi prostate cancer detection gleason score urology prostate-speci fic antigen serum relationship phi 0 pro-prostate signi ficantly prostate-speci 10.0 ng /ml patient health index difference screening 10.0 men 50 years phi range analysis population beckman coulter psa 2.0 prostate biopsy 2.0 university assay catalona department trial sample volume cutoff propsa estimate ratio sokoll access ficant diagnosis gleason 7 bootstrap tertile ficantly access immunoassay system prostate cancer screening rectal examination fpsa assays gleason score 7 grade coulter beckman risk assessment p 2psa assay university feinberg school group